Member Info for BOJO2020

That’s the Guardian article I was dissatisfied with but she has backed it up with conviction. She is forgiven!

Thanks Chester, Researcher and all the rest. In the main excellent contributions on the BB and I have learned a lot about Angle, liquid biopsy, assays and the whole area of CTC’s. Why not a word for AN himself!

Thanks Everyone. Keep your chin up and have a fantastic New Year with Angle. Remember what this company has to offer is unique and not just hype. It will make a difference in time.

Researcher,

I think we are all suffering from a bit of FDA fatigue to some degree. I just wish somehow that we were a year father down the line with the commercial operations. I think FDA may be putting the breaks on peoples decision making, but in the longer term it will all work out.

Personally I am bursting to find news on the ovarian study. What deals may that unlock! What other deals are lined up for the commercial operations? This is the substantive part of the business the bod have more control of and is therefore more real.

Sure, FDA will be great when it comes through but it’s has turned into a bit of a circus due to uncontrollable circumstances.

ATB

By cross reactive are we talking about exposure to different strains? For example wuhan and the original SA variant (in the case of Covidity). If I have that bit correct then adding reactions from AZ, Pfizer etc would add something else come the next part of our trial…Even though 1st generation vaccines were based on wuhan. Lots of swings and roundabouts and possible permutations, but it could put us in the running over the next period or so at least.

Just to clarify, the competition has now ended as the US markets opened yesterday! Oh well, just a bit of fun anyway and it put the Scancell name out there.

It’s is surprising how many people get the lingo and science and can get keyed into what our fantastic scientists are doing straight off the bat!

Anyway, looking for more ways to represent this investment in a sensible and factual way.

Good Luck

Can I make a suggestion for all you tweeters out there!

Paul Hill from VOX Markets is compiling a list of top tips for 2022! I have already replied suggesting Scancell on the basis of Covidity and it’s multiple targets (strains and Nucleocapsid).

It would be great if you could tweet a reply briefly explaining why you tip Scancell. Maybe SCIB1, Modi1 etc or all of the above!

https://twitter.com/capitalpmh/status/1475095816067026946?s=21

This gets you to the article. I will leave it with you guys. VOX has a good following…

Rats,

In that scenario would Redmile be able to use CLN, thereby adding cash and not crossing 30%? Or am I confused!?!

Hi C7,

The time to be concerned (or excited) is when we actually know what is happening... Surely we can wait days to find out by RNS?

ATB

Doh! Missed link…

https://www.scancell.co.uk/share-info

Hi all,

Hope you are having a good Christmas.

This is the major shareholders as of 8th December 2021.

So we can see that 41million shares is in the region of 5% of the issued share capital.

It’s certainly intriguing but nothing to be concerned about IMO.

ATB

200k @ 9.31 reported as a sell…

Notrader,

For the avoidance of doubt, by reading each RNS pertaining to relevant tenement’s, one can ascertain which are 100% owned. For example see this RNS states fully 100% owned.

https://www.lse.co.uk/rns/GGP/havieron-lookalike-targets-identified-18l51i387uzxlhi.html

ATB

Thanks tenzing, interesting approach…

No mention of the Nucleocapsid!

Might this been some kind of house keeping transaction and not in the strictest sense a trade? Between trading zones/jurisdictions for example…

https://www.lse.co.uk/rns/GGP/update-re-havieron-joint-venture-rsd7s9fzp0lvtzi.html

Incase you missed it! Newcrest have have actioned a clause to take a further 5% in the Havierion project.

What does this mean? That Newcrest are definitely looking to go ahead with the monster mine. But the question is, how much involvement will GGP have if any? Should get a payday out of it at the very least and we may know by Feb 22.

Good news and a profit but not earth shattering?

Don’t sweat over it JakeYork, FDA was always going to be at least 18months IMO. AN saying 12 months was to keep the kids quiet.

For transparency I sold 70% @ an average of £1.31. Leaving £15k on the table to catch any uplift of ovarian study. I will buy back in on approval and yes, I am happy to miss out on the difference. Once this gets approval we know it will push £5 to £10 over time.

Can you invite balerno or is it open

Anybody know if there is a telegram group for Scancell?

ATB

Hi Maf,

My username is GrokeMurphy.

It’s seems that shares are being accumulated across the markets. Boohoo way oversold. GGP inexplicably cheap. Sells here but few buys but stable share price. Definitely there are ‘groups’ that are accumulating share at discount. Thing is, nobody on any of these stock boards can explain it! Guess we will all know soon enough and we will know for next time!